The U.S. tissue engineering market size was estimated at USD 8.1 billion in 2023 and is expected to grow at a CAGR of 13.4% from 2024 to 2030. The primary driver of this growth is the escalating demand for pioneering tissue engineering solutions that can treat chronic diseases and aid in... Read More »
April 2024The U.S. consumer genomics market size was estimated at USD 473.9 million in 2023 and is expected to grow at a CAGR of 24.9% from 2024 to 2030. Ongoing innovations in the genomic analysis field simplify consumer DNA analysis, supplementing market growth. Advancements in genetic research ... Read More »
April 2024The U.S. pharmaceutical filtration market size was estimated at USD 4.72 billion in 2023 and is expected to grow a CAGR of 5.62% from 2024 to 2030. This growth is attributed to several factors such as advancements in technology for pharmaceutical filtration products in biopharmaceutical ... Read More »
April 2024The U.S. microbial fermentation technology market size was estimated at USD 7.22 billion in 2023 and is expected to grow at a CAGR of 5.12% from 2024 to 2030. Microbial fermentation plays a vital role in bio-production, influencing cost and quality. The burgeoning biopharmaceutical secto... Read More »
April 2024The U.S. computational biology market was valued at USD 2.54 billion in 2023 and is expected to grow at a CAGR of 13.1% from 2024 to 2030. The discoveries in genomics, molecular biology, cellular & tissue engineering, bio-imaging & new drug discovery, and delivery techniques are ... Read More »
April 2024The U.S. cell separation market size was estimated at USD 3.30 billion in 2023 and is expected to grow CAGR of 7.7% from 2024 to 2030. Cell separation plays a crucial role in different applications such as in-vitro diagnostics, biologics designing and development, therapeutic protein pro... Read More »
April 2024The U.S. vitrification market size was estimated at USD 1.74 billion in 2023 and is expected to grow CAGR of 16.08% from 2024 to 2030, driven by factors such as changing sociodemographic aspects, increased infertility cases, and advanced fertility preservation techniques like IVF. Oocyte... Read More »
April 2024The U.S. antisense and RNAi therapeutics market size was estimated at USD 2.76 billion in 2023 and is expected to grow at a CAGR of 19.10% from 2024 to 2030. Multidisciplinary applications of antisense technology in various diseases, growing cancer prevalence, and favorable government in... Read More »
April 2024The U.S. exosomes market size was estimated at USD 73.58 million in 2023 and is expected to grow at a CAGR of 34.20% from 2024 to 2030. Exosome applications are advancing, which is driving market growth. Technological advancements in exosome isolation and analytical procedures are contri... Read More »
April 2024The U.S. Cell therapy market size was valued at USD 2.66 billion in 2023 and is anticipated to grow at a CAGR of 21.18% from 2024 to 2030. Major factors contributing to this growth include the growing adoption of regenerative medicine, the rising number of clinical trials on cell therapi... Read More »
April 2024The U.S. genotyping market size was estimated at USD 6.42 billion in 2023 and is expected to grow at a CAGR of 13.7% from 2024 to 2030. Rising prevalence of genetic disorders & cancer, technological advancements, increased focus on developing personalized medicine, and increasing R&a... Read More »
April 2024The U.S. circulating tumor cells market size was estimated at USD 4.45 billion in 2023 and is expected to grow at a CAGR of 12.77% from 2024 to 2030. Some key drivers are increased awareness of cancer treatment and improved healthcare facilities. Technological developments, in ... Read More »
April 2024The U.S. biotechnology instruments market was valued at USD 34.66 billion in 2023 and is expected to grow at a CAGR of 3.45% from 2024 to 2030 which can be attributed to the high demand and affordability of biotechnology instrumentation. Moreover, inclination toward manual automation in ... Read More »
April 2024The U.S. 3D cell culture market size was valued at USD 564.2 million in 2023 and is expected to grow at a CAGR of 11.0% from 2024 to 2030. The growth of the market is attributable to increasing availability of funding programs for research and development of potential alternatives for an... Read More »
April 2024The U.S. genome editing market size was estimated at USD 3.49 billion in 2023 and is expected to grow at a CAGR of 16.5% from 2024 to 2030. The growth in the genome editing market is driven by rising demand for synthetic genes, the application of CRISPR technology, and government funding... Read More »
April 2024The U.S. biotechnology market size was estimated at USD 552.40 billion in 2023 and is expected to grow at a CAGR of 12.4% from 2024 to 2030. Government support plays a major role in propelling market growth, focusing on modernizing regulatory frameworks, enhancing approval processes and ... Read More »
April 2024The U.S. biomaterials market size was estimated at USD 59.3 billion in 2023 and is expected to grow at a CAGR of 14.8% from 2024 to 2030. The surge in the need for biomaterials is tied to an increase in accidental injuries and a higher incidence of chronic diseases. Moreover, the interest in innovative biomaterials ... Read More »
April 2024The Middle East stem cell market size was estimated at USD 694.0 million in 2023 and is projected to witness a CAGR of 7.56% from 2024 to 2030. The market’s growth can be attributed to the rising prevalence of chronic diseases such as cardiovascular diseases, and cancer. Growing aw... Read More »
March 2024The U.S. cell banking outsourcing market size was estimated at USD 5.16 billion in 2023 and is expected to grow at a CAGR of 14.79% from 2024 to 2030. The driving factors for this growth include the rising cryopreservation & cell bank preparation methodologies, and escalating demand ... Read More »
March 2024The U.S. downstream processing market size was estimated at USD 11.35 billion in 2023 and is expected to grow at a CAGR of 14.3% from 2024 to 2030. Major players are focused on streamlining the downstream process and reducing the overall cost of the procedure and the product. Downstream ... Read More »
March 2024